News
Neurizon Therapeutics has reported positive topline results from an open-label extension (OLE) study of its lead candidate ...
The ALS therapy ATH-1105 entered the brain and spinal cord at dose-proportional levels in healthy volunteers, and had a good ...
1d
Ansa on MSNItalo-US team in ALS diagnosis breakthrough
ROME, AUG 19 - An Italo-US team of scientists have made a breakthrough in the early diagnosis of amyotrophic lateral ...
Summary: A new study has uncovered why some motor neurons resist degeneration in ALS while others succumb. Researchers found ...
By analyzing millions of messenger RNA molecules (mRNA) during the course of ALS, researchers at Stockholm University, in ...
Jodi O’Donnell-Ames founded Hope Loves Company to provide support, resources, and community to children affected by ALS.
Yet another biotech is facing a delay from the FDA as the agency reels from intense staffing cuts. | Yet another biotech is ...
1d
HealthDay on MSNFDA approves ketamine product for surgical pain management
The U.S. Food and Drug Administration has approved the ketamine product, KETARx, for use in surgical pain management.
1d
Live Science on MSNNew brain implant can decode a person's 'inner monologue'
A new brain-computer interface can decode a person's inner speech, which could help people with paralysis communicate.
A Jacksonville woman's experience caring for her husband with ALS has formed a foundation to help other families fighting ...
Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disease predominantly affecting upper and lower motor neurons. Here, the authors outline previous and current efforts to characterize ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results